Mirae Asset Global Investments Co., Ltd. Pacira Bio Sciences, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $54.3 Billion
- Q1 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 21,077 shares of PCRX stock, worth $408,261. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21,077
Previous 21,973
4.08%
Holding current value
$408,261
Previous $741,000
17.0%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding PCRX
# of Institutions
289Shares Held
48.6MCall Options Held
156KPut Options Held
623K-
Black Rock Inc. New York, NY7.91MShares$153 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.11MShares$99 Million0.0% of portfolio
-
Frontier Capital Management CO LLC1.91MShares$37.1 Million0.55% of portfolio
-
State Street Corp Boston, MA1.9MShares$36.9 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.88MShares$36.5 Million0.09% of portfolio
About Pacira BioSciences, Inc.
- Ticker PCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,824,200
- Market Cap $888M
- Description
- Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...